Maria T Huayllani

Dr. Maria T Huayllani

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2019 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
DRDavid J. Restrepo
David J. Restrepo
DBDaniel Boczar
Daniel Boczar
MHMaria T Huayllani
Maria T Huayllani
ASAndrea Sisti
Andrea Sisti
EGEmmanuel Gabriel
Emmanuel Gabriel
Antonio Jorge ForteAntonio Jorge Forte
Antonio Jorge Forte
Background/Aim: The aim of this study was to analyze how race, income, insurance, and education, affect breast reconstruction rates. Materials and Methods: We reviewed the National Cancer Database. χ2 test and binary logistic regression were used to analyze the association between demographic characteristics and reconstruction rate. Results: White race and private insurance were associated with a higher risk of getting reconstruction when compared to black race (odd ratio [OR]=0.939; 95%CI=0.909-0.970) and government insurance (OR=0.459; 95%CI=0.447-0.471). Patients with an estimated income >$63,000 were found to have higher odds of receiving breast reconstruction than patients with income less than $38,000 (OR=1.868; 95%CI=1.792-1.948). Patients who live in a zip code area with a higher education average have higher odds of receiving postmastectomy breast reconstruction than patients living in a zip code with a lower education average (OR=1.152, 95%CI=1.104-1.203). Conclusion: Differences in reconstruction rates exist based on race, income, insurance, and education level.

1 April 2019 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
JPJeremie Oliver Piña
Jeremie Oliver Piña
AEAnnica C. Eells
Annica C. Eells
ESElias S. Saba
Elias S. Saba
DBDaniel Boczar
Daniel Boczar
DRDavid J. Restrepo
David J. Restrepo
Antonio Jorge ForteAntonio Jorge Forte
Antonio Jorge Forte

24 January 2021 in Journal of Cancer Survivorship
Verified
Journal Article
Closed access
PDF file
GGGunel Guliyeva
Gunel Guliyeva
MHMaria T Huayllani
Maria T Huayllani
DBDaniel Boczar
Daniel Boczar
FVFrancisco Rafael Avila Verduzco
Francisco Rafael Avila Verduzco
XLXiaona Lu
Xiaona Lu
Antonio Jorge ForteAntonio Jorge Forte
Antonio Jorge Forte

12 March 2021 in Microsurgery
Verified
Journal Article
Open access
PDF file
Antonio Jorge ForteAntonio Jorge Forte
Antonio Jorge Forte
DBDaniel Boczar
Daniel Boczar
MHMaria T Huayllani
Maria T Huayllani
FVFrancisco Rafael Avila Verduzco
Francisco Rafael Avila Verduzco
GGGunel Guliyeva
Gunel Guliyeva
TKTheodore A. Kung
Theodore A. Kung
Background: In recent years, magnetic resonance imaging lymphangiography (MRL) has emerged as a way to predict if patients are candidates for lymphedema surgery, particularly lymphovenous anastomosis (LVA). Our goal was to conduct a systematic review of the literature on the use of MRL for preoperative planning in lymphedema surgery. We hypothesized that MRL could add valuable information to the standard preoperative evaluation of lymphedema patients.Methods: On February 17, 2020, we conducted a systematic review of the PubMed/MEDLINE, Cochrane Clinical Answers, and Embase databases, without time frame or language limitations, to identify articles on the use of MRL for preoperative planning of lymphedema surgery. We excluded studies that investigated other applications of magnetic resonance imaging, such as lymphedema diagnosis and treatment evaluation. The primary outcome was the examination capacity to identify lymphatic anatomy and the secondary outcome was the presence of adverse effects.Results: Of 372 potential articles identified with the search, nine studies fulfilled the eligibility criteria. A total of 334 lymphedema patients were enrolled in these studies. Two studies compared MRL findings with those of other standard examinations (indocyanine green lymphography [ICG‐L] or lymphoscintigraphy). No adverse effects due to MRL were reported. A study shown that MRL had higher sensitivity to detect lymphatic vessel abnormalities compared with lymphoscintigraphy and a statistically higher chance of successful LVA was observed when the results of MRL agreed with those of ICG‐L (p < .001).Conclusions: MRL could be useful for preoperative planning in lymphedema surgery. The scientific evidence has been limited, so further studies with greater numbers of patients and cost analysis are necessary to justify the addition of MRL to current preoperative protocols.

11 May 2020
Verified
Journal Article
Open access
Andrea SistiAndrea Sisti
Andrea Sisti
MHMaria T Huayllani
Maria T Huayllani
DBDaniel Boczar
Daniel Boczar
DRDavid J Restrepo
David J Restrepo
ASAaron Spaulding
Aaron Spaulding
Antonio Jorge ForteAntonio Jorge Forte
Antonio Jorge Forte
Breast cancer is the most common cancer in women in the United States. National Cancer Database (NCDB) is one of the largest tumor databases of the United States. This study aimed to evaluate the features of breast cancer in women from a large updated database. We describe and analyze the frequencies and percentages of the clinical and pathological features of women diagnosed with breast cancer registered in NCDB, in a period from 2004 to 2015. A total of 2,423,875 women were diagnosed with breast cancer between 2004 and 2015. The nationally representative analysis demonstrated that the incidence of breast cancer among women increased over the years. Upper-outer quadrant was the most frequent primary tumor site, and the intraductal carcinoma was the most frequent histology. The prevalence of breast cancer increased with age. The most frequent grade at diagnosis was grade II. Broadly, invasive characteristics were noted more frequently in younger patients. Left and right breast were affected with almost the same frequency, with a slight predominance of the left breast. The most frequent surgical treatment was a partial mastectomy. Reconstruction with implant was the most frequent choice. Post-mastectomy radiation therapy was administered in the majority of patients. To the authors' knowledge, the current study is the largest descriptive analysis to date on the clinical and pathological features of breast cancer in a population-based database. The increase in incidence over the years indicates an important need for etiologic research and innovative approaches to improve breast cancer prevention.

9 November 2020 in Journal of the American Academy of Orthopaedic Surgeons
Verified
Journal Article
Closed access
BWBenjamin K. Wilke
Benjamin K. Wilke
DSDouglas S. Schultz
Douglas S. Schultz
MHMaria T Huayllani
Maria T Huayllani
DBDaniel Boczar
Daniel Boczar
ASAaron Spaulding
Aaron Spaulding
Antonio Jorge ForteAntonio Jorge Forte
Antonio Jorge Forte
Introduction: Indocyanine green (ICG) angiography is a novel technology that has been predictive of postoperative wound complications. It is unknown whether this technology can successfully predict complications after sarcoma resection. In this study, we aimed to evaluate the sensitivity and specificity of ICG angiography in predicting postoperative wound complications after soft-tissue sarcoma resection. Methods: A prospective cohort study of 23 patients was performed beginning October 2017 at our institution. Patients who underwent soft-tissue sarcoma resection were included. After tumor resection and wound closure, evaluation of tissue perfusion in skin edges was performed with ICG angiography. Wound complications were recorded in the postoperative follow-up. Results: Eight patients developed postoperative wound complications. Six patients were predicted to have wound complications on the final ICG scans. The accuracy of ICG angiography was dependent on the anatomic location, with improved accuracy in the lower extremity. ICG angiography had a sensitivity of 50%, a specificity and a positive predictive value of 100%, and a negative predictive value of 70% for wound complications after soft-tissue sarcoma resections located in the lower extremity. Conclusion: ICG angiography has a high predictive value in the lower extremity for postoperative wound complications. Level of Evidence: Level III, Diagnostic